Zielinski CC - Search Results

1

Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer.

Brodowicz T, Koestler WJ, Tomek S, Vaclavik I, Herscovici V, Wiltschke C, Steger GG, Zielinski CC. Brodowicz T, et al. Among authors: zielinski cc. Anticancer Drugs. 2000 Mar;11(3):149-53. doi: 10.1097/00001813-200003000-00002. Anticancer Drugs. 2000. PMID: 10831273 Clinical Trial.

2

Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer.

Rasoul-Rockenschaub S, Zielinski CC, Müller C, Tichatschek E, Popow-Kraupp T, Kunz C. Rasoul-Rockenschaub S, et al. Among authors: zielinski cc. Cancer Immunol Immunother. 1990;31(3):191-5. doi: 10.1007/BF01744736. Cancer Immunol Immunother. 1990. PMID: 2159848 Free PMC article.

3

Impaired production of tumor necrosis factor in breast cancer.

Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J. Zielinski CC, et al. Cancer. 1990 Nov 1;66(9):1944-8. doi: 10.1002/1097-0142(19901101)66:9<1944::aid-cncr2820660916>3.0.co;2-w. Cancer. 1990. PMID: 2224791

4

Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.

Rasoul-Rockenschaub S, Zielinski CC, Kubista E, Vavra N, Pospischil E, Staffen A, Czerwenka K, Aiginger P, Spona J. Rasoul-Rockenschaub S, et al. Among authors: zielinski cc. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1067-72. doi: 10.1016/0277-5379(89)90390-8. Eur J Cancer Clin Oncol. 1989. PMID: 2759162

5

Serum osteocalcin levels in breast cancer patients.

Pietschmann P, Zielinski C, Woloszczuk W. Pietschmann P, et al. J Cancer Res Clin Oncol. 1989;115(5):456-8. doi: 10.1007/BF00393337. J Cancer Res Clin Oncol. 1989. PMID: 2808485

6

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC. Krainer M, et al. Among authors: zielinski cc. Cancer. 1995 Jan 15;75(2):539-44. doi: 10.1002/1097-0142(19950115)75:2<539::aid-cncr2820750217>3.0.co;2-4. Cancer. 1995. PMID: 7529130

7

Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.

Wiltschke C, Krainer M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Exp Hematol. 1995 May;23(5):402-6. Exp Hematol. 1995. PMID: 7536681 Clinical Trial.

8

In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.

Wiltschke C, Krainer M, Nanut M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. J Interferon Cytokine Res. 1995 Mar;15(3):249-53. doi: 10.1089/jir.1995.15.249. J Interferon Cytokine Res. 1995. PMID: 7584671

9

[The significance of adhesion molecules in oncology].

Budinsky AC, Wiltschke C, Brodowicz T, Krainer M, Djavanmard MP, Zielinski CC. Budinsky AC, et al. Among authors: zielinski cc. Wien Klin Wochenschr. 1995;107(15):443-50. Wien Klin Wochenschr. 1995. PMID: 7676683 Review. German.

10

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: zielinski cc. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters